help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, Y.-H.
Right arrow Articles by Swaab, D. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, Y.-H.
Right arrow Articles by Swaab, D. F.
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 12 5898-5906
Copyright © 2003 by The Endocrine Society

Molecular Changes Underlying Reduced Pineal Melatonin Levels in Alzheimer Disease: Alterations in Preclinical and Clinical Stages

Ying-Hui Wu, Matthijs G. P. Feenstra, Jiang-Ning Zhou, Rong-Yu Liu, Javier Sastre Toranõ, Hendrikus J. M. Van Kan, David F. Fischer, Rivka Ravid and Dick F. Swaab

Anhui Geriatric Institute (Y.-H.W., J.-N.Z., R.-Y.L.), First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui People’s Republic of China; Netherlands Institute for Brain Research (Y.-H.W., M.G.P.F., D.F.F., R.R., D.F.S.), Meibergdreef 33, 1105 AZ Amsterdam, The Netherlands; and Department of Clinical Pharmacy (J.S.T., H.J.M.V.K.), Academic Medical Center, University of Amsterdam, 1100 DE Amsterdam, The Netherlands

Address all correspondence and requests for reprints to: Jiang-Ning Zhou, M.D., Ph.D., Anhui Geriatric Institute, First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui People’s Republic of China. E-mail: anhuigi{at}mail.hf.ah.cn.

A disturbed sleep-wake rhythm is common in Alzheimer disease (AD) patients and correlated with decreased melatonin levels and a disrupted circadian melatonin rhythm. Melatonin levels in the cerebrospinal fluid are decreased during the progression of AD neuropathology (as determined by the Braak stages), already in cognitively intact subjects with the earliest AD neuropathology (Braak stages I-II) (preclinical AD). To investigate the molecular mechanisms behind the decreased melatonin levels, we measured monoamines and mRNA levels of enzymes of the melatonin synthesis and its noradrenergic regulation in pineal glands from 18 controls, 33 preclinical AD subjects, and 25 definite AD patients. Pineal melatonin levels were highly correlated with cerebrospinal fluid melatonin levels. The circadian melatonin rhythm disappeared because of decreased nocturnal melatonin levels in both the preclinical AD and AD patients. Also the circadian rhythm of ß1-adrenergic receptor mRNA disappeared in both patient groups. The precursor of melatonin, serotonin was stepwise depleted during the course of AD, as indicated by the up-regulated monoamine oxidase A mRNA and activity (5-hydroxyindoleacetic acid:serotonin ratio). We conclude that a dysfunction of noradrenergic regulation and the depletion of serotonin by increased monoamine oxidase A result in the loss of melatonin rhythm already in preclinical AD.

This work was supported by the China Committee of the Royal Netherlands Academy of Arts and Sciences (01CDP019, 02CDP014), the National Key project for Basic Science of China (G1999054007), the Hersenstichting Nederland, and the Research Institute for Diseases in the Elderly, the Ministry of Education and Science, and the Ministry of Health, Welfare, and Sports through The Netherlands Organization for Scientific Research.

Abbreviations: AD, Alzheimer disease; CSF, cerebrospinal fluid; DA, dopamine; 5-HIAA, 5-hydroxyindoleacetic acid; HIOMT, hydroxyindole-O-methyltransferase; 5-HT, serotonin; HVA, homovanilic acid; MAO, monoamine oxidase; MHPG, 3-methoxy-4-hydroxyphenylglycol; NA, noradrenalin; NAT, N-acetyltransferase; SCN, suprachiasmatic nucleus; TPH, tryptophan hydroxylase; Trp, tryptophan.




This article has been cited by other articles:


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
J. L. Martin, M. R. Marler, J. O. Harker, K. R. Josephson, and C. A. Alessi
A Multicomponent Nonpharmacological Intervention Improves Activity Rhythms Among Nursing Home Residents With Disrupted Sleep/Wake Patterns
J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2007; 62(1): 67 - 72.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
Y.-H. Wu, D. F. Fischer, A. Kalsbeek, M.-L. Garidou-Boof, J. van der Vliet, C. van Heijningen, R.-Y. Liu, J.-N. Zhou, and D. F. Swaab
Pineal clock gene oscillation is disturbed in Alzheimer's disease, due to functional disconnection from the "master clock"
FASEB J, September 1, 2006; 20(11): 1874 - 1876.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Ackermann, R. Bux, U. Rub, H.-W. Korf, G. Kauert, and J. H. Stehle
Characterization of Human Melatonin Synthesis Using Autoptic Pineal Tissue
Endocrinology, July 1, 2006; 147(7): 3235 - 3242.
[Abstract] [Full Text] [PDF]


Home page
Br J OphthalmolHome page
M A Mainster
Violet and blue light blocking intraocular lenses: photoprotection versus photoreception
Br J Ophthalmol, June 1, 2006; 90(6): 784 - 792.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society